ArticleRheumatology and therapy2022

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib.

Ara Dikranian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.